<DOC>
	<DOCNO>NCT01488214</DOCNO>
	<brief_summary>Systemic sclerosis rare disease vascular involvement systemic fibrosis . This disease usually think spare central nervous system . However , neuropsychiatric manifestation like depression cognitive function impairment seem frequent . Pathophysiology neuropsychiatric manifestation currently unknown . White matter hyperintensities report suggested CNS vascular manifestation systemic sclerosis . Whether CNS vascular involvement play role neuropsychiatric manifestation systemic sclerosis unknown . The primary objective prospective multicentre study ass link neuropsychiatric manifestation CNS involvement systemic sclerosis . Secondary objective assess frequency neuropsychiatric manifestation , compare central nervous system abnormality scleroderma patient healthy subject . Central nervous system involvement neuropsychiatric manifestation systematically assessed central nervous system image questionnaire .</brief_summary>
	<brief_title>Neuropsychiatric Scleroderma Study : Systematic Evaluation Neuropsychiatric Involvement Systemic Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<criteria>Male female 18 65 yo With scleroderma ( American College Rheumatology and/or Leroy et Medsger ) Informed consent give Other autoimmune disease non french native speaker severe arterial hypertension diabetes anemia renal insufficiency cranial trauma history neurological disorder neurotoxic treatment pregnancy breast feed impossibility non compliance perform protocol flow chart contra indication MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Systemic Sclerosis</keyword>
	<keyword>neuropsychiatric manifestation</keyword>
	<keyword>magnetic resonance imaging</keyword>
</DOC>